CIPLA ENTECAVIR entecavir (as monohydrate) 0.5 mg film coated tablets

البلد: أستراليا

اللغة: الإنجليزية

المصدر: Department of Health (Therapeutic Goods Administration)

العنصر النشط:

entecavir monohydrate, Quantity: 0.532 mg

متاح من:

Cipla Australia Pty Ltd

INN (الاسم الدولي):

entecavir monohydrate

الشكل الصيدلاني:

Tablet, film coated

تركيب:

Excipient Ingredients: hyprolose; magnesium stearate; crospovidone; lactose monohydrate; microcrystalline cellulose; titanium dioxide; hypromellose; macrogol 6000

طريقة التعاطي:

Oral

الوحدات في الحزمة:

30, 10

نوع الوصفة الطبية :

(S4) Prescription Only Medicine

الخصائص العلاجية:

CIPLA ENTECAVIR is indicated for the treatment of chronic hepatitis B virus infection in adults 16 years or older with evidence of active liver inflammation.,This indication is based on histologic, virologic, biochemical and serological responses in nucleoside-treatment na?ve and lamivudine-resistant adult patients with HBeAg-positive or HBeAg-negative chronic HBV infection with compensated liver disease.

ملخص المنتج:

Visual Identification: white to off-white, triangular shaped, biconvex, film coated tablet, debossed with 'E' on one side and plain on the other side.; Container Type: Blister Pack; Container Material: Al/Al; Container Life Time: 36 Months; Container Temperature: Store below 30 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

الوضع إذن:

Licence status A

تاريخ الترخيص:

2016-12-19